Stock screener

LCTX

Conviction 19HealthcareScan · Thu, Jun 25, 2026
LCTX$1.22-3.17%
ResistanceSupportVol 14
63 bars
Vol MA14 1.25M
Mar 26Apr 14May 1May 19Jun 8Jun 25
Lineage Cell Therapeutics, Inc.BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.lineagecell.com
Price1.22
Change-3.17%
Gap-0.40%
Rel volume1.55×
Avg volume1.16M
Avg $ vol1.44M
SMA 201.24
SMA 501.36
SMA 2001.60
Price vs 50-10.18%
Price vs 200-23.57%
MA stackbearish
50/200 cross
Supertrenddown · 1.43
RSI (14)44
MACD hist0.01
MACD cross
Stoch %K / %D29 / 46
ADX (14)18
+DI / −DI11 / 18
RSI divergence
MACD divergence
ATR %+5.53%
ADR %5.01%
52w high1.96
52w low0.8977
From 52w high-37.76%
Above 52w low+35.90%
New 52w highNo
SqueezeOn · 13d
Bollinger width12.56%
%B0.37
Donchian pos21.62%
Donchian high1.37
Donchian low1.18
AVWAP (52w high)1.62
vs AVWAP high-24.71%
AVWAP (52w low)1.51
vs AVWAP low-19.39%
OBV trendFlat
Chaikin MF (20)-0.38
Today vs 20d1.55×
Avg vol (14d)1.25M
Avg vol (20d)1.16M
Avg $ vol (20d)1.44M
Market cap304.14M
RS 3m (vs SPY)-27.12%
RS 6m (vs SPY)-32.74%
RS line new highNo
Trend template2/8
Technical rank17.6
1 week-2.40%
1 month-5.43%
3 months-21.29%
6 months-29.48%
1 year+12.96%
YTD-25.61%
P/E-4.79
P/B5.65
P/S20.89
P/FCF-15.64
EPS-0.2800
Div yield
ROE-117.93%
ROA-58.00%
Debt/Eq
Current6.89
EV/EBITDA-7.44
Gross margin56.84%
Net margin-436.47%
Rev growth53.24%
EPS growth-241.41%
Price target
Target upside
Analyst rating
Institutional
Ent. value268.2M
Revenue1.73M
Net income-4.81M
Gross profit1.08M
Free cash flow-19.44M
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ExchangeNYSE
Shares out249.3M
Employees77
ListedThu, Mar 5, 1992
Free float196.6M
Float %78.9%
Short interest26.08M
Days to cover25.0d
Short volume38.5%
Squeeze score60 / 100
Next earnings
EPS forecast
Last EPS vs est
Last surprise
Setup gradeD
Conviction19 / 100
Pattern quality
Tech rank17.6 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction
Pattern family
Resistance1.36
Support1.18
Days since event
Candle confirm
News sentiment

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in LCTX

All disclosures →
No recent disclosed trades by Congress in LCTX. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in LCTX

No recent insider (Form 4) filings in LCTX. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in LCTX · 1 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.